휴젤
181,500KRWMarket close of 10/28 (Wed)
Up +1.17%+2,100KRWMarket close of 10/28 (Wed)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/29 (Thu)183,300KRWUp +0.99%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 179,400
- High
- 183,000
- Low
- 179,400
- Day range
- Day range low 179,400 high 183,000, open 179,400, close 181,500, previous close 179,400
- Volume
- 3×10K shares
- 4.8B KRW 0.51× the 20-session average
Market close of 10/28 (Wed)
Where it sits in the 1-year range
10%1-year close range 168,500 to 296,500 won, 10% up from the low
10% of the way up from the lowest close in 1 year (252 sessions) · -38.8% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28Points to check
- Recent filingsnot verifiedCould not read filing data, so not verified
- Foreign & institutionalnot verifiedFlow is dated 2026-10-29 and price is dated 2026-10-28; flow is not combined into this check.
- Daily moveusual range+1.17%+1.17%, 0.6× the usual (20-session average ±1.99%)That day +1.17% · usual ±1.99% · large-move threshold ±4.0%
The other 2 are within the usual range
- Trading value0.5×usual range
- EarningsOperating income, 8 quarters
See the full check report
Loading
Same sector · 제약
Up +0.44%· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +6.1% | Up +0.64% | 80.0B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -0.9% | Down -0.15% | 68.9B KRW |
| 파마리서치 | Close over the last 20 sessions -27.8% | Down -1.30% | 43.9B KRW |
| 한미약품 | Close over the last 20 sessions -27.1% | Up +5.42% | 42.3B KRW |
| 삼익제약 | Close over the last 20 sessions -13.1% | Up +9.54% | 34.5B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 18 days
- Next data 10/30 (Fri) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.